Life expectancy estimation with breast cancer: Bias of the declining exponential function and an alternative to its use

Medical Decision Making

Volumn 19, Issue 4, 1999, Pages 385-393

  Holland, Robert R ^a,d   Ellis, Charles A ^c   Geller, Berta M ^a,b,e   Plante, Dennis A ^b   Secker Walker, Roger H ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c Insight Data Analysis Inc   (United States)

^d Insight Data Analysis Inc ^*  (United States)

^e Vermont College of Medicine   (United States)

Author keywords

DEALE; Life expectancy; Markov model; Misestimation bias; Misspecification bias; Mortality; Survival

Indexed keywords

ACCURACY; ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OUTCOMES RESEARCH; PROBABILITY;

EID: 0032828698     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X9901900406     Document Type: Article

References (27)

1. Leu-is B. Breast cancer. In: Wyngarden J, Smith L, Bennett J (eds). Cecil Textbook of Medicine, Philadelphia, PA: W. B. Saunders, 1992:1381-6.
2. Henderson I. Breast cancer. In: Isselbacher K, Braunwald E, Wilson J (eds). Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 1998:1840-50.
3. Wright J, Weinstein M. Gains in life expectancy from medical interventions-standardizing data on outcomes. N Engl J Med. 1998;339:380-6.
4. Detsky A, Redelmeier D. Measuring health outcomes-putting gains into perspective [editorial]. N Engl J Med. 1999;339:402-3.
5. Lee E. Some well-known survival distributions and their applications. In: Lee E (ed). Statistical Methods for Survival Data Analysis. New York: John Wiley & Sons. 1992:131-4.
6. Kuntz K, Weinstein M. Life expectancy biases in clinical decision modeling. Med Decis Making. 1995;15:158-69.
7. Beck J, Kassirer J, Pauker S. A convenient approximation of life expectancy (the DEALE): 1) Validation of the method, and 2) Use in medical decision making. Am J Med. 1982;73:883-97.
8. Kattlove H, Liberati A, Keeler E, Brook R. Benefits and cost of screening and treatment for early breast cancer: development of a basic benefit package. JAMA. 1995;273:142-8.
9. Beck J, Pauker S. The Markov process in medical prognosis. Med Decis Making. 1983;3:419-28.
10. Sonnenberg F, Beck J. Markov models in medical decision making: a practical guide. Med Decis Making. 1993;13:322-38.
11. Lindfors K, Rosenquist J. The cost-effectiveness of mammographic screening strategies. JAMA. 1995;274:881-4.
12. Rosenquist C, Lindfors K. Screening mammography beginning at age 40 years: a reappraisal of cost-effectiveness. Cancer. 1998;82:2235-40.
13. Rosenquist C, Lindfors K. Screening mammography in women aged 40-49 years: analysis of cost-effectiveness. Radiology. 1994;191:647-50.
14. Lindfors K, Rosenquist C. Needle core biopsy guided with mammography: a study of cost-effectiveness. Radiology. 1994;190:217-22.
15. Hillner B, Smith T. Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision analysis model. N Engl J Med. 1991;324:160-8.
16. Hillner B, Smith T, Desch C. Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision analysis while awaiting clinical trials. JAMA. 1992;267:2055-61.
17. Verhoef C, Stalpers L, Verbeek A, Wobbes T, van Daal W. Breast-conserving treatment or mastectomy in early breast cancer: a clinical decision analysis with special reference to the risk of local recurrence. Eur J Cancer. 1991;27:1132-7.
18. Schrag D, Kuntz K, Garber J, Weeks J. Decision analysis-effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med. 1997;336:1465-71.
19. Benbassat J, Zajicek G, Van Ooortmarssen G, Ben-dov I, Eckman M. Inaccuracies in estimates of life expectancies with bronchial cancer in clinical decision making. Med Decis Making. 1993;13:237-44.
20. Djulbegovic B. An estimation of life expectancy: the method is a message, (commentary). Med Decis Making. 1993;13:245-6.
21. Yakovlev A, Tsodikov A, Boucher K, Kerber R, Allison CJ. The shape of the hazard function in breast carcinoma: curability of the disease revisted. Cancer. 1999;85:1789-98.
22. U.S. Department of Health and Human Services. SEER Cancer Incidence Public-Use Database, 1973-1995. Information Management Services, Inc., Silver Spring, MD 20904, 1999.
23. Chiang C. The life table and its construction - the complete life table. In: Chiang C (ed). The Life Table and Its Applications. Malabar, FL: Robert E. Krieger, 1984:113-36.
24. Chiang C. Statistical inference regarding life table functions. In: The Life Table and Its Applications. Malabar, FL, Robert E. Krieger, 1984:153-67.
25. SEER cancer statistics review, 1973-1995. Section 4-Breast. 〈http://www-seer.ims.nci.nih.gove/Publications/CSR7395/ breastpdf〉 1999.
26. GMWK291. Death rates from 72 selected causes by 5-year age groups, race, and sex United States, 1979-96. 〈http://www.cdc.gov/nchswww/datawh/statab/unpubd/mortabs.htm〉, 1999.
27. Salzmann P, Kerlikowske K, Phillips K. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age. Ann Intern Med. 1997;127:955-65.